CDISC standards shape how clinical trial data are interpreted at the point of regulatory review. Reviewers rely on consistent structure, traceability, and controlled terminology to assess safety and efficacy with confidence.
When datasets do not align with these expectations, it can lead to validation findings, data queries, or delays that impact critical milestones. Many of these issues emerge late in the submission timeline. At that stage, resolving them can require significant rework across multiple functions, increasing pressure on teams and introducing additional regulatory risk.
A clear understanding of where CDISC compliance breaks down allows teams to address risks earlier. With the right processes and oversight in place, sponsors can strengthen dataset quality and approach submission with greater confidence.
What Are Common Errors That Disrupt CDISC Compliance?
Validation errors in CDISC datasets often surface during final quality checks, but their root causes are usually embedded much earlier in the study. These issues affect both the structural integrity of the datasets and the ability of reviewers to interpret the data as intended. When left unresolved, they can lead to Pinnacle 21 rejects, additional queries, and delays in submission timelines.
| Error | Description | Common Causes |
|---|---|---|
| Missing required variables/data | Missing necessary variables or datasets such as USUBJID, SUBJID, DOMAIN, AE.AESTDTC, AE.AEOUT, or DS.DSDECOD | Required data not collected, incomplete CRF design, or incorrect mapping during programming |
| Missing or incorrect trial summary (TS.XPT) dataset | Trial Summary (TS) domain is missing or contains invalid entries that define study design and key metadata | Incorrect dataset structure, invalid TSVAL entries, or lack of understanding of TS requirements |
| Start date is after end date | Date variables such as AESTDTC occur after corresponding end dates like AEENDTC | Data collection errors, incorrect ISO 8601 conversions, or programming misalignment |
| xxDTC date is after RFPENDTC | Events recorded after the subject’s participation end date | Source data inconsistencies or incorrect derivations during programming |
| Incorrect or missing codelists | Missing or inconsistent use of controlled terminology across variables and domains | Use of free text, inconsistent codelist application, or improperly defined study-specific codelists |
| Missing define.xml | Missing or incomplete define.xml file, which provides metadata and dataset structure for regulatory review | Failure to generate or validate define.xml, lack of metadata governance, or incomplete documentation processes |
| Invalid aCRF (Annotated CRF) | Annotated CRF is incomplete, incorrectly labeled, or lacks proper structure such as bookmarks and variable annotations | Inadequate annotation practices, inconsistent naming conventions, or lack of review and standardization |
There are several consistent themes across these errors: gaps in upstream data collection, inconsistencies in mapping and controlled terminology, and limited validation early in the process. These are not isolated issues, but systemic patterns that can propagate across datasets and study phases if not addressed. Recognizing these themes early allows teams to intervene upstream and reduce the risk of compounding errors later in the submission process.
CDISC Warnings That Signal Underlying Issues
Warnings in CDISC validation checks do not typically block submission, but they highlight inconsistencies that can affect data clarity, traceability, and reviewer confidence. Addressing them early helps reduce downstream questions and supports a more efficient review process.
Common warnings include:
- Inconsistent value for xxTEST within xxTESTCD
- Inconsistent xxSTRESU
- Inconsistent value for xxTPT
- Variable length is too long for actual data
- Duplicate records
- Missing value for xxORRESU, when xxORRES is provided
- Inconsistent Controlled Terminology (Units/Results)
- Invalid SUPPQUAL and RELREC Mapping
- Inconsistent Timing Variables (–STRESC vs –ORRES)
These warnings often stem from inconsistencies in source data, gaps in standardization, or oversights during mapping and validation. Applying consistent controlled terminology, aligning data collection across sources, and incorporating iterative validation checks can significantly reduce their occurrence, while also addressing the same root causes that lead to larger errors.
How Can Teams Ensure CDISC-Compliant Datasets?
Avoiding CDISC errors and warnings depends on decisions made throughout the study life cycle. When these decisions are misaligned or deferred, issues often surface late in the process, leading to rework, increased review cycles, and added pressure on submission timelines. Experienced teams take a more proactive approach, using the steps below to embed standards, alignment, and validation earlier and prevent issues from compounding.
Start With CDISC Data Standards in Mind During Study Setup
Many downstream issues originate in how data are collected, making CRFs a primary root cause area for CDISC compliance gaps. Designing CRFs with compliance in mind helps ensure required variables are captured correctly and consistently. Early alignment between data management, biostatistics, and programming teams allows studies to be set up to support SDTM and ADaM from the outset.
Standardize Data and Controlled Terminology Early
Inconsistent terminology and unit handling are common sources of both errors and warnings. Strict adherence to CDISC Controlled Terminology and applying them consistently across all data sources helps prevent discrepancies. This is particularly important when integrating data from multiple vendors or laboratories.
Build Iterative Validation Into the Programming Workflow
Validation should be an ongoing process rather than a final checkpoint. Running Pinnacle 21 checks at multiple stages of the study allows teams to identify and resolve issues as they arise. Combined with internal validation checks and structured QC, this limits the risk of introducing new issues during late-stage fixes.
Strengthen Review, Documentation, and Knowledge Sharing
Consistent peer review and clear documentation play a critical role in maintaining dataset quality. This includes structured QC reviews of datasets and programming outputs, along with clear documentation of mapping decisions, derivations, and controlled terminology usage. Capturing common issues and their resolutions in a centralized repository allows teams to learn from past studies and avoid repeating the same errors.
Leverage Experienced Biometrics Oversight
Experience brings the ability to anticipate where issues are likely to occur and address them before they impact submission timelines. Teams with deep familiarity in CDISC standards and regulatory expectations can guide study setup, mapping, and validation strategies.
Supporting Submission-Ready CDISC Datasets
CDISC compliance depends on disciplined execution and alignment across data collection, programming, and validation, supported by processes that identify and resolve issues early. Ephicacy’s CDISC gold member status and expertise in statistical programming and regulatory submissions position us as a strategic partner, helping sponsors build high-quality, submission-ready datasets with confidence.
Talk to our experts to learn how we can support your next study.
